Mercer Global Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $368K | Buy |
|
|||||
|
2025
Q1 | $331K | Sell |
|
|||||
|
2024
Q4 | $368K | Sell |
|
|||||
|
2024
Q3 | $355K | Sell |
|
|||||
|
2024
Q2 | $305K | Sell |
|
|||||
|
2024
Q1 | $413K | Buy |
|
|||||
|
2023
Q4 | $327K | Sell |
|
|||||
|
2023
Q3 | $313K | Sell |
|
|||||
|
2023
Q2 | $345K | Buy |
|
|||||
|
2023
Q1 | $377K | Buy |
|
|||||
|
2022
Q4 | $362K | Sell |
|
|||||
|
2022
Q3 | $431K | Buy |
|
|||||
|
2022
Q2 | $353K | Buy |
|
|||||
|
2022
Q1 | $394K | Buy |
|
|||||
|
2021
Q4 | $287K | Buy |
|
|||||
|
2021
Q3 | $254K | Sell |
|
|||||
|
2021
Q2 | $303K | Buy |
|